Skip to main content

Table 1 Demographic, clinical, and biochemical properties of all classes

From: Annexin A5 as a marker for hepatocellular carcinoma in cirrhotic hepatitis C virus patients

Variables

Cirrhosis with HCC group (n = 44)

Cirrhosis without HCC group (n = 47)

P1value

Control group (n = 20)

P value

Age (years)

57.7 ± 5.75

56.8 ± 6.89

0.968 (NS)

54.5(50.5–60.5)

0.337 (NS)

Sex (M/F)

23/21

27/20

0.751 (NS)

10/10

0.587 (NS)

MELD

16.1 ± 4.16

15.1 ± 4.57

0.568 (NS)

Child–Pugh class (A/B/C)

12/20/12

14/18/14

0.733 (NS)

ALT (U/L)

51 ± 17.65

53.3 ± 15.94

0.761 (NS)

11.9 ± 3.47

< 0.001* (HS)

AST(U/L)

69 ± 23.39

68.2 ± 19.51

0.944 (NS)

15.4 ± 4.83

< 0.001* (HS)

ALKP (U/L)

107.60 ± 37.05

114.40 ± 41.84

0.068 (NS)

48.6 ± 10.49

< 0.001* (HS)

GGT (mg/dl)

51.09 ± 37.75

48.94 ± 26.37

0.818 (NS)

14.6 ± 4.57

< 0.001* (HS)

INR

1.5 ± 0.47

1.59 ± 0.51

0.542 (NS)

1.005 ± 0.49

< 0.001* (HS)

PT(s)

17.51 ± 4.21

18.62 ± 4.64

0.533 (NS)

13.07 ± 0.18

< 0.001* (HS)

Total bilirubin (mg/dl)

2.55 ± 1.61

2.59 ± 2.01

0.579 (NS)

0.49 ± 0.25

< 0.001* (HS)

Albumin (g/dl)

2.97 ± 0.72

2.54 ± 0.79

0.098 (NS)

4.43 ± 0.59

< 0.001* (HS)

Platelet count (× 103/cm2)

113.04 ± 24.94

111.32 ± 17.63

0.935 (NS)

297.7 ± 17.87

< 0.001* (HS)

APRI score

1.88 ± 0.58

1.93 ± 0.61

0.794 (NS)

0.11 ± 0.03

< 0.001* (HS)

FIB-4 score

5.47 ± 1.04

5.32 ± 1.37

0.709 (NS)

0.57 ± 0.14

< 0.001* (HS)

Annexin A5 (ng/ml)

3.89 ± 0.85

3.06 ± 0.88

0.041 (S)

0.54 ± 0.11

< 0.001* (HS)

AFP (ng/ml)

270 ± 35

98 ± 20

< 0.001* (HS)

5.3 ± 2.9

< 0.001* (HS)